From apolipoprotein B exposure to subclinical atherosclerosis: A metabolic-inflammatory-vascular framework of disease conversion
Year: 2026
Type: article
Abstract: People with similar current lipid concentrations can have markedly different burdens of atherosclerosis.Much of this difference may reflect previous exposure that a single measurement cannot capture.Whether the arterial response to that exposure also helps determine when plaque develops is less well established.This narrative review examines the evidence for a metabolic-inflammatory-vascular model of disease conversion.Cumulative apolipoprotein B exposure provides the atherogenic substrate; metabolic disturbances, inflammation, and vascular dysfunction may influence its consequences within the arterial wall.Imaging identifies the resulting structural disease.The model is particularly relevant to younger asymptomatic adults, in whom low short-term cardiovascular risk may coexist with early plaque.Its central hypothesis is that a small set of biological characteristics can help explain plaque onset or progression after cumulative exposure and conventional risk factors have been accounted for.Evidence for the integrated metabolic-inflammatory-vascular signature remains indirect; it has not been prospectively validated.Testing this hypothesis requires repeated lipid measurements and prospective imaging, with susceptibility markers assessed before or early in disease.For now, the model offers a way to investigate differences in disease expression, while early and sustained reduction of atherogenic lipoproteins remains the basis of prevention.
Source: World Journal of Cardiology
DOI: 10.4330/wjc.127742
Author: Mišo Šabović
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7234358578
